Redefining the role of second transplantation in adult ALL with post-transplant relapse in the modern era of immuno-targeted therapies
To the Editor: Relapse after allogeneic hematopoietic cell transplantation (allo-HCT) remains one of the most challenging events in adult acute lymphoblastic leukemia (ALL) and a leading cause of treatment failure [1, 2]. Second allo-HCT has historically been regarded as the only potentially curative option for patient...